Loading clinical trials...
Loading clinical trials...
Financial Toxicity in Diverse Cancer Populations and Care Settings
This study will seek to generate the early data needed to understand the relationship between constructs and measures of patients' coping resources and psychological response and measures of patients' financial toxicity. To collect this early descriptive data, the overall goal of this study is to identify social, behavioral, and knowledge factors associated with financial toxicity outcomes. Identifying these factors will ultimately help elucidate targets for behavioral, psychosocial, and/or educational and coaching interventions.
PRIMARY OBJECTIVES: 1. Examine the associations between measures of self-efficacy, quality of social support, and financial literacy with the outcome measure of financial toxicity. 2. Identify the feasibility of collecting these measures in a Spanish-speaking cancer patient population. 3. Describe the relationship between financial toxicity and clinical outcomes (survival and disease status). This is an exploratory aim. 4. a) Describe the correlation between measures of self-efficacy, quality of social support, financial literacy and clinical and demographic patient characteristics with outcome measure of financial toxicity, by tumor type and age subgroups. b) Describe response rate to the financial toxicity measure (\>50% completed items on the survey instrument), by tumor type and age subgroups. This is an exploratory aim. OUTLINE: Participants will complete a survey packet that is estimated to take about 30 minutes. The survey packet will be collected at baseline and at 6 months.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
DCH Regional Medical Center
Tuscaloosa, Alabama, United States
Scripps - MD Anderson Cancer Center
La Jolla, California, United States
Baptist- MD Anderson Cancer Center
Jacksonville, Florida, United States
The Queen's Medical Center
Honolulu, Hawaii, United States
Lyndon Baines Johnson General Hospital
Houston, Texas, United States
M D Anderson Cancer Center
Houston, Texas, United States
Start Date
September 12, 2020
Primary Completion Date
September 1, 2028
Completion Date
September 1, 2028
Last Updated
October 27, 2025
625
ESTIMATED participants
Survey Administration
OTHER
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
NCT06311214
NCT05053971
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions